COLUMBIA, Md., Jan. 04, 2017 -- Digital health leader WellDoc and leading diabetes healthcare organization, the American Association of Diabetes Educators (AADE), announced today they will partner to incorporate the “AADE Diabetes Education Curriculum: A Guide to Successful Self-Management” in the BlueStar® digital therapeutic platform. BlueStar® is an FDA-cleared digital therapeutic used to help adults living with type 2 diabetes self-manage their condition.
|
|||
This partnership marks the first time AADE, a professional membership organization comprised of healthcare professionals from multiple disciplines dedicated to improving diabetes care through innovative education, management and support, has partnered with an organization to provide its curriculum in a consumer-friendly digital format. The curriculum, built around the AADE7 Self-Care Behaviors™, focuses on the seven primary areas of self-management: Healthy Eating, Being Active, Monitoring, Taking Medication, Problem Solving, Reducing Risks and Healthy Coping.
“The dual engagement of the person with diabetes and his or her clinical care team is the core of what makes BlueStar a successful tool in helping improve outcomes in type 2 diabetes by reducing A1C for our users,” said WellDoc President and CEO Kevin McRaith. “Working with AADE and its membership is both a natural and positive fit for WellDoc. The AADE curriculum is best-in-class and offering it in a consumer-friendly digital format will only further enhance the value of BlueStar.”
As part of this partnership, AADE and WellDoc will explore how to collectively engage AADE’s members. The organizations will also look to jointly develop new strategies that bring innovative tools to diabetes education and intervention through digital health channels. BlueStar currently provides a platform that allows healthcare professionals (including diabetes educators and care coordinators) to support people with type 2 diabetes in between office visits.
“Digital health is a strong complement to in-person care and education provided by diabetes educators. It is beneficial for AADE to leverage meaningful partnerships with digital health leaders, such as WellDoc, to make every tool available to people living with type 2 diabetes,” said AADE CEO Charles MacFarlane, FACHE, CAE. “Integrating our curriculum into the BlueStar platform is an important strategic decision for AADE and will benefit our members and people with type 2 diabetes in this evolving healthcare environment. We look forward to continuing to build on this relationship.”
About WellDoc®
WellDoc is a digital health technology company that develops mobile solutions to drive behavioral and clinical change in chronic disease. WellDoc’s goal is to improve patient self-management and help physicians overcome gaps in the delivery system to improve clinical outcomes and decrease cost. WellDoc has commercialized BlueStar®, a digital therapeutic, for adults with type 2 diabetes. This therapeutic is designed to fill the support gap between patients and providers during the 8700 hours that individuals live their lives outside the healthcare system each year. WellDoc has a proven track record of contributing published, peer-reviewed clinical evidence since 2008 and presented real-world patient engagement and clinical outcomes at the American Diabetes Association’s (ADA) 76th Scientific Sessions. BlueStar® is recognized by the ADA on its website as the first and only in the new class of diabetes treatment known as Mobile Prescription Therapy. In a recently published Forbes blog, WellDoc was named among one of five healthcare tech companies to watch in 2016. For more information, visit www.WellDoc.com and www.BlueStarDiabetes.com.
About American Association of Diabetes Educators (AADE):
AADE is a multi-disciplinary professional membership organization dedicated to improving diabetes care through innovative education, management and support. With more than 14,000 healthcare professional members including nurses, dietitians, pharmacists, exercise specialists, and others, AADE has a vast network of practitioners working with people who have, are affected by or are at risk for diabetes. Learn more: www.diabeteseducator.org.
Media Contact: WellDoc Juliette Bogus PressComm PR Tel: +410.980.5687 Email: [email protected] AADE Matt Eaton Tel: +312.601.4866 Email: [email protected]


Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Bank of America's $72.5M Epstein Settlement: What You Need to Know
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Apple Turns 50: From Garage Startup to AI Crossroads
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



